NTRK2 and Parkinson disease: Kang et al. (2022) showed that stimulation of deficient BDNF/TrkB signaling with the small molecular agonist CF3CN increased the number of TH-positive dopaminergic neurons and increased motor functions in MPTP-induced human SNCA transgenic PD model mice.